000 01733 a2200481 4500
005 20250515173841.0
264 0 _c20091019
008 200910s 0 0 eng d
022 _a1538-8514
024 7 _a10.1158/1535-7163.MCT-08-1188
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoldblatt, Erin M
245 0 0 _aThe telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel.
_h[electronic resource]
260 _bMolecular cancer therapeutics
_cJul 2009
300 _a2027-35 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActins
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aFluorescent Antibody Technique
650 0 4 _aFocal Adhesions
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aOligonucleotides
650 0 4 _aOligopeptides
_xpharmacology
650 0 4 _aPaclitaxel
_xpharmacology
650 0 4 _aTelomerase
_xantagonists & inhibitors
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aGentry, Erin R
700 1 _aFox, Melanie J
700 1 _aGryaznov, Sergei M
700 1 _aShen, Changyu
700 1 _aHerbert, Brittney-Shea
773 0 _tMolecular cancer therapeutics
_gvol. 8
_gno. 7
_gp. 2027-35
856 4 0 _uhttps://doi.org/10.1158/1535-7163.MCT-08-1188
_zAvailable from publisher's website
999 _c18932558
_d18932558